Q1 FY27 · Ended Sep 30, 2026 · View SEC filing
The sleep business earns more than the whole company
Equipment segment profit exceeds total operating income, because corporate, amortization and restructuring costs sit outside the segments and absorb the difference.
For investorsIs the margin dip temporary or a new cost base?
For foundersThe consumables playbook behind a device business
Operating income rose only 1.4% on 5.9% more revenue, as research, selling and transformation costs absorbed the gain.
Net income grew 20.1% against 1.4% for operating income, with the one-time MatrixCare gain supplying most of the gap.
Mask and accessory sales equal 74.9% of device sales, a recurring stream that connected software helps sustain by keeping patients on therapy.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes ResMed from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
